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This case report describes an unusual presentation of an emergency department (ED) patient with 
nausea, vomiting, and epigastric pain, who was initially suspected of having viral hepatitis. The patient 
returned to the ED seven days later with persistent tachycardia and was diagnosed with new onset 
thyrotoxicosis.
[WestJEM. 2007;8:97-100.]
INTRODUCTION
   Thyrotoxicosis is an uncommon diagnosis in the emergency 
department (ED). Vomiting and abdominal pain are 
uncommon symptoms of thyrotoxicosis, and when coupled 
with laboratory abnormalities such as transaminitis, the 
emergency physician (EP) can be misled to a diagnosis of 
hepatitis.1 With thyrotoxicosis, many cellular metabolic 
processes are affected by excess thyroid hormone production, 
resulting in tachycardia, heat intolerance, palpitations, 
sweating, fatigue and tremulousness.1 Since thyrotoxicosis 
can progress to the life-threatening thyroid storm if untreated, 
early diagnosis with thyroid function tests and early 
intervention with beta blockers and agents to reduce thyroid 
hormone production and release are necessary. We present the 
case of a patient with vomiting, dehydration, and abdominal 
pain, which nearly resulted in exploratory laparoscopy, and in 
whom thyroid function tests showed new onset thyrotoxicosis. 
CASE REPORT
   A 28-year-old female physician presented to the ED with 
nausea and vomiting for three days with epigastric pain 
and decreased urination. The vomiting was non-bloody and 
non-bilious, occurred four times per day, and the patient 
was unable to tolerate liquids. The epigastric pain was mild, 
constant, and sharp. The patient felt a rapid pulse. She denied 
fever, chills, diarrhea, melena, or prior similar episodes. 
The past medical history was unremarkable with no prior 
surgeries, medical problems, or medications. The family 
history was documented as noncontributory and the patient 
denied pregnancy and alcohol, tobacco or drug use. 
   The physical exam revealed an oral temperature of 36.7º 
C, heart rate at 131 beats/min, respirations at 18 breaths/
min, blood pressure at 128/75 mm Hg, and room air oxygen 
saturation (O2 sat) at 100%. The patient weighed 52.3 kg with 
a height of 157.5cm. She was alert and oriented, nontoxic 
and in no distress. The eye exam was normal without 
exophthalmos. There was no lymphadenopathy, no goiter 
was noted, and a thyroid exam was not documented. The 
lungs were clear and the cardiac exam was normal other 
than tachycardia. The abdomen was soft with normal bowel 
sounds, with mild tenderness in the epigastrium but no 
rebound or guarding. The neurological exam revealed normal 
cranial nerve function, full strength and sensation, and a 
normal	gait.	Deep	tendon	reflexes	were	not	documented.
   A metabolic panel including electrolytes, glucose, BUN 
and creatinine were normal. Liver function tests showed 
albumin at 3.6 g/dL(normal 3.2-5.5), AST at 118 IU/L(normal 
8-40), ALT at 197 IU/L(normal 0-60), alkaline phosphatase 
at 51 IU/L(normal 26-110), and total bilirubin at 1.5 mg/
dL(normal 0-1.4). The lipase level and complete blood count 
with differential were normal. A voided urinalysis showed 
specific	gravity	of	1.024,	pH	at	7.30,	ketones	at	150	mg/dL,	
small bilirubin, urobilinogen at 8 mg/dL, 2 red blood cells/
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cells/hpf, moderate bacteria, and no hemoglobin, leukocyte 
esterase, nitrite, protein, glucose, or crystals. A urine 
pregnancy test was negative. Bedside ED ultrasound by the EP 
showed no evidence of cholecystitis.
   The patient received two liters IV normal saline and two 
doses of antiemetics.  She then tolerated an oral liquid 
challenge, felt better and requested to be sent home. The 
discharge diagnosis was possible gastritis versus viral 
hepatitis. Lansoprazole 15 mg once daily was prescribed, with 
primary care physician (PCP) follow up in 1-2 days. A repeat 
set of vital signs was not documented.
   Seven days later, the patient returned. She had seen her PCP 
who referred her for an esophagogastroduodenoscopy (EGD). 
She had not eaten or drunk for 20 hours prior to the procedure. 
The EGD, done with fentanyl and midazolam sedation, found 
a small hiatal hernia with no other abnormalities. Because 
of persistent tachycardia in the 140s/minute with intractable 
vomiting, the patient was sent directly to the ED. The patient 
stated the vomiting had resolved since the last ED visit and 
only started again after the EGD. The epigastric pain persisted 
without change and the only additional complaint was 
tremulousness. She continued to deny fever, chills, diarrhea, 
and melena.
   The physical exam showed an oral temperature of 36.3º C, 
heart rate at 143 beats/min, respirations at 20 breaths/min, 
blood pressure at 125/61 mm Hg and O2 sat at 100% on 2L/
min oxygen per nasal cannula. The patient weighed 50 kg 
(a 2.3 kg weight loss in one week). The patient was alert, 
tremulous and appeared fatigued. The remainder of the exam 
was unchanged. She received supplemental oxygen, three 
liters IV normal saline, and cardiac monitoring.
A repeat complete metabolic panel showed normal glucose 
and electrolytes except for bicarbonate at 19 mEq/L(normal 
25-34), magnesium at 1.8 mg/dL(normal 1.8 – 2.5), albumin 
at 3.2 g/dL, AST at 83 IU/L, ALT at 87 IU/L, alkaline 
phosphatase at 48 IU/L, and total bilirubin at 0.8 mg/dL. A 
serum lipase level and complete blood count with differential 
were within normal limits. The erythrocyte sedimentation 
rate and C-reactive protein were normal. A urinalysis was 
not repeated. An EKG showed a narrow-complex sinus 
tachycardia at a rate of 152 beats/min with no ischemic ST or 
T wave changes. In addition, she had thyroid function tests 
sent, which are performed once daily by our institution’s 
laboratory. The patient tolerated oral liquids after antiemetics. 
Despite hydration, the patient’s tachycardia persisted at 130 
beats/min. She appeared fatigued but had resolution of all 
other presenting symptoms. The patient was admitted to the 
internal	medicine	service	on	a	telemetry	floor.
   Overnight she received two more liters IV normal saline, 
followed by maintenance rate. A right upper quadrant 
ultrasound showed a markedly thickened gallbladder wall 
without	gallstones,	a	small	amount	of	pericholecystic	fluid,	
and a normal common bile duct. Radiology recommended 
a CT scan of the abdomen and pelvis, which showed small 
bilateral pleural effusions, periportal edema, upper abdominal 
ascites, marked gallbladder wall thickening, and moderate 
amount	of	free	fluid	in	pelvis.	
   The next day general surgery recommended an exploratory 
laparoscopy. This procedure was delayed because the patient 
ate	breakfast.	The	first	two	thyroid	function	panels	sent	from	
the ED and on hospital day two were invalid due to hemolysis, 
but a third set showed a free thyroxine (T4) level greater 
than 6 ng/dL(normal 0.8-1.9) and an undetectable thyroid- 
stimulating hormone (normal 0.5-5 mIU/L). After atenolol and 
methimazole, the patient improved and was discharged on the 
third hospital day with diagnoses of new onset thyrotoxicosis, 
dehydration, liver hemangioma, and small hiatal hernia. 
DISCUSSION
   Nausea, vomiting and abdominal pain are common 
complaints in the ED. However, they are uncommon signs 
of thyrotoxicosis.1 Thyrotoxicosis is uncommon itself, with 
a lifetime prevalence of 0.5% and an annual incidence of 30 
cases per 100,000 persons per year. It occurs in a male-to-
female ratio of 1:5-10.2 In British studies, the incidence is 
reported as high as 100-200 cases per 100,000 population 
per year.3,4  Although uncommon, it is important to detect 
thyrotoxicosis early due to the risk of life-threatening thyroid 
storm, which carries a mortality of 20-50% if untreated.5
   Patients with thyrotoxicosis typically present in a 
hypermetabolic state with sympathetic activation. The 
symptoms include anxiety or nervousness, psychosis, 
weight loss, excessive hunger, hyperdefecation, menstrual 
irregularities, pretibial edema, fever, heat intolerance, 
hyperhidrosis, goiter, ophthalmopathy (thyrotoxic stare/
lid	retraction),	hyperreflexia,	palpitations,	tachycardia,	
hypertension,	heart	failure,	and	atrial	fibrillation.6,7,8,9  A list 
of signs and symptoms in descending order of frequency 
is shown in Table 1. Our patient presented only with 
tachycardia,	vomiting,	and	abdominal	pain	during	her	first	
visit, the latter two signs being uncommon in thyrotoxicosis. 
However, thyrotoxicosis has infrequently been associated with 
gastroparesis, resulting in abdominal pain and nausea. It was 
not until her return visit that she was noted to be tremulous.10 
   Like our patient, women in their third through sixth decade 
of life are at highest risk for thyrotoxicosis.6 Although our 
patient was not pregnant, excess exposure to thyroid hormone 
in utero is associated with high spontaneous abortion rates of 
up to 22%.11 
  Other rarely reported presentations of thyrotoxicosis include 
diabetic ketoacidosis in a previously well-controlled diabetic, 
near-fatal cardiac arrhythmias, and hypokalemic periodic 
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paralysis.12,13 In addition, a previous case report discussed 
multi-organ dysfunction characterized by lactic acidosis and 
liver failure.14  Our patient did have an acidosis (bicarbonate 
19 mEq/L) and although not in frank liver failure, did have 
elevated transaminases.
   Since rapid thyroid function testing is unavailable in most 
EDs, the diagnosis of thyrotoxicosis is largely clinical. 
Persistent	tachycardia,	diffuse	goiter,	and	hyperreflexia	
should sway the emergency physician to strongly consider 
thyrotoxicosis. Elevated levels of thyroxine (T4) and 
triiodothyronine (T3) with depressed thyroid-stimulating 
hormone (TSH) are diagnostic.6  Modest elevations in glucose 
(30-55% of patients), calcium (10% of patients), bilirubin, and 
transaminases (rare) may be 
Table 1. Clinical Findings in Thyrotoxicosis.
Clinical 
Manifestations
Percent Clinical 
Manifestations
Percent
Tachycardia 100 Weakness 70
Goiter 98 Increased appetite 65
Nervousness 99 Eye complaints 54
Skin changes 97 Leg swelling 35
Tremor 97 Hyperdefacation 33
Sweating 91 Diarrhea 23
Hypersensitivity to heat 89 Atrial	fibrillation 10
Palpitations 89 Splenomegaly 10
Fatigue 88 Gynecomastia 10
Weight loss 85 Anorexia 9
Bruit over thyroid 77 Liver palms 8
Dyspnea 75 Constipation 4
Eye Signs 71 Weight Gain 2
Williams RH. J Clin Endocrinol Metab 1946:6:1. 
seen, as well as a mild normochromic normocytic anemia.6  
Our patient had evidence of dehydration on her urinalysis 
(specific	gravity	of	1.024)	and	chemistry	panel	(BUN/
creatinine ratio greater than 20), but repeat vital signs during 
her initial visit were not documented to see if hydration had 
resolved her tachycardia. In addition, a family history was 
not documented which would have suggested the diagnosis in 
the ED, since it was later found that her mother had Graves’ 
disease.
The most common causes of thyrotoxicosis include diseases 
of primary hyperthyroidism with Graves’ disease as the most 
common cause (60-70%). This was our patient’s ultimate 
diagnosis by her endocrinologist. Other causes of primary 
hyperthyroidism include toxic multinodular goiter (15-
30%) and iodine intake (rare). Thyroiditis (painful subacute, 
silent subacute, postpartum, radiation induced; 20%), 
central hyperthyroidism (pituitary adenoma; 3-5%), and 
nonthyroid diseases (ectopic thyroid tissue from stroma 
ovarii, metastatic thyroid cancer; rare) can also cause 
thyrotoxicosis. Drug ingestions and medication side effects 
precipitating thyrotoxicosis are rare.5
   Drug-induced hyperthyroidism is linked to dietary 
supplements, especially metabolic boosters containing T3 
or its derivatives, iodine-containing medications including 
indinovir and cough medications, and intentional or 
unintentional overingestion of levothyroxine. Iodine should 
also be avoided during imaging studies as this can worsen 
thyrotoxicosis. Our patient had a CT scan with iodine 
contrast without documented effects. However, the thyroid 
uptake scan could not be interpreted due to the use of iodine. 
Another series reported an epidemic of thyrotoxicosis, 
ultimately attributed to beef products contaminated 
with bovine thyroid hormone.16 Perhaps one of the most 
notorious medications associated with thyroid dysfunction 
is amiodarone. In a case study published in 2005, more than 
27% of cardiac patients started on amiodarone had thyroid 
dysfunction; 7% were thyrotoxic.15 
   Management of a patient with thyrotoxicosis depends 
on the clinical presentation. Mild hyperthyroidism may 
be managed with judicious outpatient care, whereas 
moderate to severe thyrotoxicosis or thyroid storm requires 
emergent treatment. Initial therapy consists of stabilization: 
airway	protection,	oxygenation,	intravenous	fluids	and	
cardiorespiratory monitoring.5 Fever should be managed with 
acetaminophen and cooling techniques. Dehydration should 
be	addressed	with	appropriate	fluid	replacement.	Ultimately,	
anti-thyroid medications and beta-blockers should be 
started while precipitating factors such as infection, trauma, 
cerebrovascular accident, myocardial infarction, general 
surgery,	and	medication	reactions	identified	and	managed	
accordingly.5
   Following stabilization, the treatment goal is to inhibit 
hormone synthesis and release, prevent conversion of T4 to 
T3, and block hormone action in the periphery.6 Inhibition 
of synthesis is accomplished by thioamides [propylthiouracil 
(PTU), methimazole] which block thyroid peroxidase. PTU 
is preferred as it blocks peripheral conversion of T4 to T3.  
   Lithium and iodine both inhibit hormone release. 
However,	lithium	is	difficult	to	titrate,	and,	therefore,	iodine	
is preferred.5		In	order	to	prevent	iodine	organification	
(Wolff-Chaikoff effect), thioamides should be given at least 
one hour before iodine therapy.5 Peripheral conversion, 
accounting for 85% of circulating T3, is impeded by PTU, 
propranolol, and dexamethasone.6 The sympathomimetic 
effects of thyroid hormone are also managed with 
propranolol, which can reduce dysrhythmias, fever, tremors, 
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palpitations, and anxiety.6 If clinical deterioration occurs 
in spite of appropriate therapy, thyroid hormone may 
be removed via exchange transfusion, plasmapheresis, 
or charcoal plasmaperfusion, the latter being cited in 
textbooks but rarely done in clinical practice.6 Our patient 
was ultimately treated with methimazole and atenolol and 
showed clinical improvement prior to discharge.
   Although our case is an unusual presentation of an 
uncommon disease, it is prudent to focus on the learning 
points from the initial ED visit. Our patient presented with 
vomiting, tachycardia, and a urine analysis consistent 
with her initial diagnosis of dehydration. Hypovolemia-
induced	tachycardia	should	resolve	after	adequate	fluid	
resuscitation.17 During her second presentation, our patient 
was persistently tachycardic despite three liters of IV 
normal saline. Persistent tachycardia mandates a search for 
other causes including acute anemia, pulmonary embolism, 
arrhythmia, sepsis, toxic ingestions (sympathomimetic 
or anticholinergic agents), sedative/hypnotic withdrawal, 
hyperthyroidism, or other hyperadrenergic state. Further, a 
family history for autoimmune disorders suggests Graves’ 
disease.	Our	patient	was	also	found	to	have	free	fluid	in	her	
pelvis and a thickened gall bladder wall, almost resulting in 
laparoscopy. Since there are no reports of gallbladder wall 
thickening	associated	with	thyrotoxicosis,	this	finding	is	
best explained by overhydration, which is a known cause 
of ascites and gallbladder wall thickening.18,19 Our patient 
received 5 liters IV normal saline within eight hours of her 
arrival and continued at a maintenance rate.
CONClUSION
     Thyrotoxicosis is an uncommon disease; however, its 
detection is important, as thyroid storm can develop if 
left untreated, carrying a mortality of 20-50%. Thyroid 
function testing is not available in most EDs. Therefore, 
diagnosis of thyrotoxicosis is largely clinical and relies on 
a thorough history and physical exam, including evaluation 
of family history. A repeat set of vital signs is necessary 
prior to discharging any patient, and a thorough evaluation 
for unexplained tachycardia is warranted. Thyrotoxicosis 
may present with abdominal pain and vomiting while 
other characteristic features are absent. The therapy for 
thyrotoxicosis consists of PTU, iodine and beta blockers. 
Moderate to severe thyrotoxicosis warrants admission to 
the hospital.
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